Progression‐free survival in oncological clinical studies: Assessment time bias and methods for its correction

Progression‐free survival (PFS) is a frequently used endpoint in oncological clinical studies. In case of PFS, potential events are progression and death. Progressions are usually observed delayed as they can be diagnosed not before the next study visit. For this reason potential bias of treatment e...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pharmaceutical statistics : the journal of the pharmaceutical industry 2021-07, Vol.20 (4), p.864-878
Hauptverfasser: Miltenberger, Robert, Götte, Heiko, Schüler, Armin, Jahn‐Eimermacher, Antje
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!